Page last updated: 2024-09-03

nnc 112 and naxagolide

nnc 112 has been researched along with naxagolide in 1 studies

Compound Research Comparison

Studies
(nnc 112)
Trials
(nnc 112)
Recent Studies (post-2010)
(nnc 112)
Studies
(naxagolide)
Trials
(naxagolide)
Recent Studies (post-2010) (naxagolide)
3237159849

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexoff, D; Carter, P; Fowler, JS; Kang, Y; Kim, D; Kim, SW; King, P; Logan, J; Muench, L; Shea, C; Skolnick, P; Volkow, ND1

Other Studies

1 other study(ies) available for nnc 112 and naxagolide

ArticleYear
Therapeutic doses of buspirone block D3 receptors in the living primate brain.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:8

    Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Benzazepines; Benzofurans; Buspirone; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Functional Neuroimaging; Globus Pallidus; Injections, Intramuscular; Mesencephalon; Oxazines; Papio anubis; Positron-Emission Tomography; Raclopride; Radioligand Assay; Receptors, Dopamine D3

2014
chemdatabank.com